BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1837963)

  • 21. Predominance of high molecular weight plasma Na(+)-K(+)-ATPase inhibitor in essential hypertension.
    Gonick HC; Weiler EW; Khalil-Manesh F; Weber MA
    Am J Hypertens; 1993 Aug; 6(8):680-7. PubMed ID: 8217031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma.
    Holm B; Nilsen DW; Kierulf P; Godal HC
    Thromb Res; 1985 Jan; 37(1):165-76. PubMed ID: 3983897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous radioimmunoassay for plasma arginine-vasopressin and oxytocin using DEAE Sephadex A 25 extraction.
    Chiodera P; Louis F; Legros JJ
    J Endocrinol Invest; 1984 Aug; 7(4):287-93. PubMed ID: 6501802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma transforming growth factor beta(1) and platelet activation: implications for studies in transplant recipients.
    Coupes BM; Williams S; Roberts IS; Short CD; Brenchley PE
    Nephrol Dial Transplant; 2001 Feb; 16(2):361-7. PubMed ID: 11158413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standardization of beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4): a collaborative study to establish international standards for beta-TG and PF4.
    Kerry PJ; Curtis AD
    Thromb Haemost; 1985 Feb; 53(1):51-5. PubMed ID: 2581331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunoassay of beta-thromboglobulin. False high values from frozen plasma samples.
    Fiskerstrand CE; Burnet EM; Anderton JL
    Am J Clin Pathol; 1988 Nov; 90(5):610-2. PubMed ID: 2972195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reliability of a single beta-thromboglobulin measurement in a diabetic population: importance of PGE1 in anticoagulant mixture. Damad Study Group.
    Scarabin PY; Strain L; Ludlam CA; Jones J; Kohner EM
    Thromb Haemost; 1987 Apr; 57(2):201-4. PubMed ID: 2955540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
    Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
    J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of high molecular weight urokinase and low molecular weight urokinase.
    Nobuhara M; Sakamaki M; Ohnishi H; Suzuki Y
    J Biochem; 1981 Jul; 90(1):225-32. PubMed ID: 7026550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioimmunoassay of thyroxine and triiodothyronine in urine using extraction and separation of Sephadex columns.
    Rogowski P; Siersbaek-Nielsen K
    Scand J Clin Lab Invest; 1977 Dec; 37(8):729-34. PubMed ID: 601507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of precursor and secreted forms of human angiotensinogen.
    Campbell DJ; Bouhnik J; Coezy E; Menard J; Corvol P
    J Clin Invest; 1985 Jun; 75(6):1880-93. PubMed ID: 2989336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A coated-tube radioimmunoassay for beta-thromboglobulin.
    Kuronen B; Kauppinen HL; Rasi V; Kekomäki R; Myllylä G
    Med Biol; 1980 Oct; 58(5):264-8. PubMed ID: 6163045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of ELISA for specific measurement of high-molecular-weight (HMW) adiponectin.
    Tanita T; Miyakoshi H; Nakano Y
    J Immunol Methods; 2008 Apr; 333(1-2):139-46. PubMed ID: 18304569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Beta-thromboglobulin (beta-TG)].
    Uchiumi H
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():734-7. PubMed ID: 15658437
    [No Abstract]   [Full Text] [Related]  

  • 35. Beta-thromboglobulin in urine and plasma: influence of coronary risk factors.
    Mundal HH; Hjemdahl P; Urdal P; Kierulf P; Perneby C; Berg K; Gjesdal K
    Thromb Res; 1998 Jun; 90(5):229-37. PubMed ID: 9694245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the in vitro fibrinolytic activities of low and high molecular weight single-chain urokinase-type plasminogen activator.
    de Munk GA; Groeneveld E; Rijken DC
    Thromb Haemost; 1993 Sep; 70(3):481-5. PubMed ID: 8259553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High molecular weight transforming growth factor beta is excreted in the urine in active nodular sclerosing Hodgkin's disease.
    Newcom SR; Tagra KK
    Cancer Res; 1992 Dec; 52(24):6768-73. PubMed ID: 1458464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated thrombotic activity after myocardial infarction: A 2-year follow-up study.
    Martínez-Sales V; Vila V; Réganon E; Goberna MA; Ferrando F; Palencia MA; Aznar J
    Haemostasis; 1998; 28(6):301-6. PubMed ID: 10461012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for the platelet specificity of beta-thromboglobulin and studies on its plasma concentration in healthy individuals.
    Ludlam CA
    Br J Haematol; 1979 Feb; 41(2):271-8. PubMed ID: 85458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Various properties and kinetics of interaction of high and low molecular weight human kininogens with human plasma kallikrein].
    Nartikova VF; Egorova TP; Rets EV; Paskhina TS
    Biokhimiia; 1986 Mar; 51(3):463-71. PubMed ID: 3634630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.